Assistant Professor, Pathology, UC, Davis School of Medicine
Pathology
Dr. Mingyi Chen, MD
|
|
Give Review
Dr. Mingyi Chen works in the field of Pathology. Mingyi Chen is a published doctor. He has 17 publications published. The most current publication "Detection of Epstein-Barr virus (EBV) in human lymphoma tissue by a novel microbial detection array." He accepts Medicare payments and is registered with Medicare.gov.
Publications
- Therapeutic Benefit of Bortezomib on Acute Graft-versus-Host Disease Is Tissue Specific and Is Associated with Interleukin-6 Levels.
- Mice deficient in Rbm38, a target of the p53 family, are susceptible to accelerated aging and spontaneous tumors.
- Adiposity induces lethal cytokine storm after systemic administration of stimulatory immunotherapy regimens in aged mice.
- Revealing the substrate origin of the linear dispersion of silicene/ag(111).
- Increased Antitumor Effects Using IL-2 with Anti-TGF-β Reveals Competition between Mouse NK and CD8 T Cells.
- Treatment of Chronic graft versus host disease with bortezomib.
- Nanomicelle formulation modifies the pharmacokinetic profiles and cardiac toxicity of daunorubicin.
- Aging predisposes to Acute inflammatory induced pathology after tumor immunotherapy.
- Circulating plasma cells with Russell bodies in osteosclerotic Myeloma.
- Colonic graft-versus-host Disease (GVHD) manifesting as eosinophilic colitis following autologous hematopoietic stem cell transplantation.
- Murine natural killer cell licensing and regulation by T regulatory cells in viral responses.
- Mantle cell Lymphoma and involvement of the orbit and ocular adnexa.
- Detection of Epstein-Barr virus (EBV) in human Lymphoma tissue by a novel microbial detection array.
- Hematological Disorders following Gastric Bypass Surgery: Emerging Concepts of the Interplay between Nutritional Deficiency and Inflammation.
- Direct experimental determination of onset of electron-electron interactions in gap opening of zigzag graphene nanoribbons.
- Anti-proliferative but not anti-angiogenic tyrosine kinase inhibitors enrich for cancer stem cells in soft tissue sarcoma.
Conditions Treated
- Acute Leukemia
- Anemia
- Chronic Myeloid Leukemia (CML)
- Coagulation Disorders (incl. Hemophilia)
- View All
Doctors Specialties
- Hematology
- Hematopathology
- Pathology
Accepted Insurances
- Blue Card PPO
- CaliforniaCare HMO
- Advantage Preferred DirectAccess Plus PPO
- Blue Cross Blue Shield of California PPO
- Pathway X Guided Access HMO
- Select Plus HMO
- Select PPO
- Cigna HMO
- Blue & Gold HMO
- Covered California - Bronze PPO
- Employer Group HMO
- Health Net PPO
- Individual and Family PPO
- Humana
- Medicare MCR
- Molina
- National Elevator
- Heritage Signature
- Choice Plus POS
- Navigate HMO
- Navigate POS
- Options PPO
- United Healthcare
Hospital
-
University of California, Davis Medical Center
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1861606303 |
| Last Name Of The Provider | CHEN |
| First Name Of The Provider | MINGYI |
| View All |
Similar Doctors
|
|
Dr. Brian Bull, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jeremy K. Deisch, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Paul C. Herrmann, MD |
|
|
Dr. Darryl G. Heustis, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Mie M. Thinn, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Gayathri Nagaraj, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Hannah H. Wong, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Craig Zuppan, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Sonia S. Kalaria, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. John K. Wong, MD |